Published in Virology on February 01, 1991
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol (2000) 2.74
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol (2003) 2.57
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Effective vaccine for lassa fever. J Virol (2000) 1.74
Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol (1999) 1.65
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2003) 1.56
Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32
Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs. J Virol (1994) 1.30
Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol (2009) 1.19
Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06
5' termini of Pichinde arenavirus S RNAs and mRNAs contain nontemplated nucleotides. J Virol (1995) 1.03
Genome comparison of virulent and avirulent strains of the Pichinde arenavirus. Arch Virol (2008) 1.01
Genomic and phylogenetic characterization of Merino Walk virus, a novel arenavirus isolated in South Africa. J Gen Virol (2010) 0.97
Cross-species analysis of the replication complex of Old World arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol (2011) 0.96
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. Virus Genes (2006) 0.88
Identification of virulence determinants within the L genomic segment of the pichinde arenavirus. J Virol (2013) 0.84
Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opin Drug Discov (2012) 0.82
Watching every step of the way: junín virus attenuation markers in the vaccine lineage. Curr Genomics (2013) 0.76
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Glycoprotein detection in nitrocellulose transfers of electrophoretically separated protein mixtures using concanavalin A and peroxidase: application to arenavirus and flavivirus proteins. Anal Biochem (1982) 2.02
Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol (1982) 1.77
Capsid protein diversity among Norwalk-like viruses. Virus Genes (2000) 1.72
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J Virol (1997) 1.45
Sequential translation of capsid and membrane protein genes of alphaviruses. Nature (1975) 1.45
Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol (1993) 1.43
Initiation of synthesis of the structural proteins of Semliki Forest virus. J Mol Biol (1975) 1.42
Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet (1987) 1.28
Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates. AIDS Res Hum Retroviruses (1990) 1.24
Polyadenylic acid sequences in the virus RNA species of cells infected with Semliki Forest Virus. J Gen Virol (1974) 1.22
Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine (1997) 1.21
Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol (1998) 1.18
Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine (2001) 1.11
RNA polymerase components in Semliki Forest virus-infected cells: synthesis from large precursors. J Gen Virol (1976) 1.08
Automated contingent reinforcement of correct posture. Res Dev Disabil (1987) 1.07
Sequence analysis of the V3 loop regions of the env genes of Ugandan human immunodeficiency proviruses. AIDS Res Hum Retroviruses (1991) 1.03
In vitro synthesis of structural proteins of Semliki Forest virus directed by isolated 26 S RNA from infected cells. FEBS Lett (1974) 1.02
Regulation of the synthesis of Sindbis virus-specified RNA: role of the virion core protein. J Gen Virol (1978) 0.92
Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection. J Gen Virol (1990) 0.91
Molecular cloning of Lassa virus RNA: nucleotide sequence and expression of the nucleocapsid protein gene. Virology (1985) 0.91
Structural and cell-associated proteins of Lassa virus. J Gen Virol (1983) 0.90
The controlled dissociation of proteins from rat liver ribosomes by potassium chloride. Eur J Biochem (1970) 0.88
Conformational changes in Sindbis virus E1 glycoprotein induced by monoclonal antibody binding. J Gen Virol (1983) 0.86
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1994) 0.84
Oral delivery of micro-encapsulated DNA vaccines. Dev Biol Stand (1998) 0.84
Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen. Lancet (1989) 0.83
Sequence of the nucleocapsid protein gene of Machupo virus: close relationship with another South American pathogenic arenavirus, Junín. Arch Virol (1992) 0.83
Identification of neighbouring proteins in E. coli 50S ribosomes. FEBS Lett (1975) 0.81
Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents. J Gen Virol (1998) 0.78
Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene. Viral Immunol (1996) 0.76
Expression of neurofilament L-promoter green-fluorescent protein constructs in immortalized Schwann cell-neuron coculture. Neurosci Lett (1999) 0.76
Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein. Dev Biol (Basel) (2000) 0.75
Differentiation of a Schwann cell line expressing reporter genes in the presence and absence of nerve axons. Biochem Soc Trans (1997) 0.75
Coordinate mutation and transformation of mouse fibroblasts: induction by nitroquinoline oxide and modulation by caffeine. Carcinogenesis (1981) 0.75
Possible approaches to a vaccine against Lassa fever. Trans R Soc Trop Med Hyg (1984) 0.75
Expression of Lassa virus nucleocapsid gene fragments in bacteria. Med Microbiol Immunol (1986) 0.75
Wide-band frequency-modulation system using optical techniques. Appl Opt (1979) 0.75
Translation of the genes for the structural proteins of alphaviruses. Med Biol (1975) 0.75
Neurological gene therapy. Sci Prog (1997) 0.75